Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Single-center Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05116540
What this trial is testing

Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hope Biosciences Research Foundation 24
Post-approval studies (Phase 4)Study completedNCT01706510
What this trial is testing

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients

Who this might be right for
Coronary Artery Disease
Rapid City Regional Hospital, Inc 28
Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT05848596
What this trial is testing

Handwashing Knowledge and Practice of Palliative Care

Who this might be right for
Hand Hygiene
Istanbul Sultanbeyli State Hospital 60
Early research (Phase 1)Study completedNCT02303678
What this trial is testing

D2C7 for Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaBrain Tumor, Recurrent
Darell Bigner 81
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Early research (Phase 1)WithdrawnNCT01437280
What this trial is testing

GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers

Who this might be right for
TumorsSolid Tumors
Baylor College of Medicine
Testing effectiveness (Phase 2)Active Not RecruitingNCT07177196
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for a Single Participant With PRPH2 Mutation Associated With Retinal Dystrophy

Who this might be right for
Retinal Dystrophy
n-Lorem Foundation 1
Large-scale testing (Phase 3)Study completedNCT02610868
What this trial is testing

Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults

Who this might be right for
Sialorrhea
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187
Not applicableStudy completedNCT06636591
What this trial is testing

Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer

Who this might be right for
Breast Cancer FemaleHER2-negative Breast Cancer
Fudan University 14
Early research (Phase 1)Study completedNCT06450223
What this trial is testing

Bioequivalence Study of Perampanel Tablets 12 mg

Who this might be right for
Epilepsy
Humanis Saglık Anonim Sirketi 30
Testing effectiveness (Phase 2)Study completedNCT03558191
What this trial is testing

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 156
Not applicableStudy completedNCT06054997
What this trial is testing

Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation

Who this might be right for
Lung Transplantation
University Hospital, Motol 141
Early research (Phase 1)Study completedNCT05275010
What this trial is testing

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Who this might be right for
Healthy Male Subjects
Hoffmann-La Roche 151
Not applicableStudy completedNCT00971724
What this trial is testing

Biomarkers of Prednisolone Treatment (P05888)

Who this might be right for
Insulin ResistanceHyperglycemiaGlucose Intolerance
Merck Sharp & Dohme LLC 72
Testing effectiveness (Phase 2)Study completedNCT04849559
What this trial is testing

Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Vanda Pharmaceuticals 27
Testing effectiveness (Phase 2)Ended earlyNCT01095887
What this trial is testing

Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplant
Mayo Clinic 6
Large-scale testing (Phase 3)Study completedNCT03738865
What this trial is testing

G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

Who this might be right for
Insulin HypoglycemiaType 1 Diabetes MellitusSevere Hypoglycemia
Xeris Pharmaceuticals 132
Not applicableLooking for participantsNCT07632534
What this trial is testing

Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops.

Who this might be right for
Dry Eye Syndrome (DES)Dry Eye
Centre Hospitalier Universitaire de Saint Etienne 68
Early research (Phase 1)Study completedNCT05319899
What this trial is testing

ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 18
Next Page